Suppr超能文献

一名感染人类免疫缺陷病毒的患者外用咪喹莫特乳膏治疗面部疣

Treatment of facial verrucae with topical imiquimod cream in a patient with human immunodeficiency virus.

作者信息

Cutler K, Kagen M H, Don P C, McAleer P, Weinberg J M

机构信息

Department of Dermatology, New York Medical College-Metropolitan Hospital Center, NY, USA.

出版信息

Acta Derm Venereol. 2000 Mar-Apr;80(2):134-5.

Abstract

Imiquimod is a recently developed imidazoquinolin heterocyclic amine that is an immune response modifier. Treatment with topical 5% imiquimod cream has shown promising results in the treatment of genital warts in immunocompetent individuals. We report here the first case of successful treatment with topical 5% imiquimod cream of facial verrucae in an individual with human immunodeficiency virus.

摘要

咪喹莫特是一种最近研发的咪唑喹啉杂环胺,属于免疫反应调节剂。外用5%咪喹莫特乳膏治疗免疫功能正常个体的尖锐湿疣已显示出有前景的结果。我们在此报告首例外用5%咪喹莫特乳膏成功治疗一名感染人类免疫缺陷病毒个体面部疣的病例。

相似文献

9
Plantar warts treated with an immune response modifier: a report of two cases.
Clin Exp Dermatol. 2003 Nov;28 Suppl 1:45-7. doi: 10.1046/j.1365-2230.28.s1.15.x.
10
Successful treatment of butcher's warts with imiquimod 5% cream.5%咪喹莫特乳膏成功治疗屠夫疣
Clin Exp Dermatol. 2003 Nov;28 Suppl 1:42-4. doi: 10.1046/j.1365-2230.28.s1.14.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验